M M Hsu

Summary

Affiliation: National Taiwan University
Country: Taiwan

Publications

  1. ncbi request reprint Clinical application of two new serological tests of Epstein-Barr virus in nasopharyngeal carcinoma
    Mow Ming Hsu
    Department of Otolaryngology, National Taiwan University Hospital, 7 Chung Shan S Road, Taipei, Taiwan
    Gan To Kagaku Ryoho 29:202-7. 2002
  2. ncbi request reprint Specific IgA antibodies to recombinant early and nuclear antigens of Epstein-Barr virus in nasopharyngeal carcinoma
    M M Hsu
    Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan
    Clin Otolaryngol Allied Sci 26:334-8. 2001
  3. ncbi request reprint Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases
    M M Hsu
    Department of Otolaryngology, National Taiwan University Hospital, 7 Chung Shan S Road, Taipei, Taiwan
    Arch Otolaryngol Head Neck Surg 127:798-802. 2001
  4. ncbi request reprint Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
    R L Hong
    Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei
    J Clin Oncol 19:4305-13. 2001
  5. ncbi request reprint Use of bacterially expressed EBNA-1 protein cloned from a nasopharyngeal carcinoma (NPC) biopsy as a screening test for NPC patients
    M R Chen
    Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan
    J Med Virol 64:51-7. 2001
  6. ncbi request reprint Salvage surgery for recurrent nasopharyngeal carcinoma
    M M Hsu
    Department of Otolaryngology, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Arch Otolaryngol Head Neck Surg 123:305-9. 1997
  7. pmc Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
    R L Hong
    Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei
    Br J Cancer 80:1962-7. 1999
  8. ncbi request reprint Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma
    J Y Ko
    Department of Otolaryngology, National Taiwan University Hospital, Taipei
    Arch Otolaryngol Head Neck Surg 124:578-81. 1998
  9. ncbi request reprint Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men
    Y C Chien
    Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    N Engl J Med 345:1877-82. 2001
  10. ncbi request reprint Intracranial relapse of nasopharyngeal carcinoma manifested as sudden deafness
    Y H Young
    Department of Otolaryngology, College of Medicine, National Taiwan University, Taipei
    Otol Neurotol 22:392-6. 2001

Collaborators

  • C J Chen
  • J Y Chen
  • W C Hsu
  • Ruey Long Hong
  • M R Chen
  • C L Kao
  • C C Tsai
  • Y F Ho
  • A Hildesheim
  • Paul H Levine
  • Sophia S Wang
  • C Y Lin
  • Alex Chang
  • A T Chan
  • Yu Juen Cheng
  • J Y Ko
  • Czau Siung Yang
  • I How Chen
  • Jenq Yuh Ko
  • Ching Ting Tan
  • Amy Pickard
  • Mei Ying Liu
  • En Yu Cho
  • W C Chie
  • A L Cheng
  • Y H Young
  • Y C Chien
  • P J Lou
  • T S Sheen
  • Shih Hsuan Hsiao
  • Juen Haur Hwang
  • Scott R Diehl
  • Beth L Mittl
  • Alisa M Goldstein
  • Deborah D Ruggles
  • Sheng Ping Chou
  • T H Yeh
  • Brenda Sun
  • Jerry Chuang
  • Louise A Brinton
  • L L Ting
  • Beth F Mittl
  • Hsin Huang
  • Yunglin D Ma
  • Yin Chu Chien
  • Helen Huei Hsin Hsu
  • Cheng Tai Luo
  • C C Lai
  • Jing Fen Chang
  • Julia Chang
  • Sang Hue Yen
  • Chin Fu Hsiao
  • Kuang Y Chen
  • Tso Ching Lee
  • Pei Jer Chen
  • Chao A Hsiung
  • Yuh Shan Jou
  • Guan Lu Lin
  • B R Lin
  • H S Yu
  • M Y Liu
  • M H Pan
  • J K Lin
  • Y S Pu
  • T M Chen
  • Y J Wang
  • J T Lin
  • C H Hsu
  • G S Chen
  • M K Lai
  • S H Jee
  • T S Shen
  • H I Yang
  • C Y Hsieh
  • W Ming-Shiang
  • C S Yang
  • L T Lui
  • P Tran Ba Huy
  • S Y Lee
  • M C Tsai

Detail Information

Publications23

  1. ncbi request reprint Clinical application of two new serological tests of Epstein-Barr virus in nasopharyngeal carcinoma
    Mow Ming Hsu
    Department of Otolaryngology, National Taiwan University Hospital, 7 Chung Shan S Road, Taipei, Taiwan
    Gan To Kagaku Ryoho 29:202-7. 2002
  2. ncbi request reprint Specific IgA antibodies to recombinant early and nuclear antigens of Epstein-Barr virus in nasopharyngeal carcinoma
    M M Hsu
    Department of Otolaryngology, National Taiwan University Hospital, Taipei, Taiwan
    Clin Otolaryngol Allied Sci 26:334-8. 2001
    ..This assay should be useful for early diagnosis and mass screening of patients...
  3. ncbi request reprint Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases
    M M Hsu
    Department of Otolaryngology, National Taiwan University Hospital, 7 Chung Shan S Road, Taipei, Taiwan
    Arch Otolaryngol Head Neck Surg 127:798-802. 2001
    ..To analyze the factors affecting overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site after a full course of radiotherapy...
  4. ncbi request reprint Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
    R L Hong
    Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei
    J Clin Oncol 19:4305-13. 2001
    ..Because mitomycin is active against hypoxic and G0 cells, which may help to eradicate micrometastasis, we investigated the effect of mitomycin-containing cisplatin-based induction chemotherapy...
  5. ncbi request reprint Use of bacterially expressed EBNA-1 protein cloned from a nasopharyngeal carcinoma (NPC) biopsy as a screening test for NPC patients
    M R Chen
    Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan
    J Med Virol 64:51-7. 2001
    ..The optimum combination is VCA plus EBNA-1, which can identify 92.5% (287/310) of NPC patients, and shows a specificity of 92.7% (242/261) for normal individuals...
  6. ncbi request reprint Salvage surgery for recurrent nasopharyngeal carcinoma
    M M Hsu
    Department of Otolaryngology, College of Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Arch Otolaryngol Head Neck Surg 123:305-9. 1997
    ..To assess the efficacy of salvage surgery for patients with recurrent nasopharyngeal carcinoma (NPC) at the primary site after radiotherapy...
  7. pmc Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study
    R L Hong
    Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei
    Br J Cancer 80:1962-7. 1999
    ..The response rate and overall survival of MAP-FL were better than series previously reported even when a subset of patients with poor prognosis was selected. MAP-FL's role as neoadjuvant or adjuvant therapy is worthy of further study...
  8. ncbi request reprint Increased mutagen sensitivity in patients with head and neck cancer is less pronounced in patients with nasopharyngeal carcinoma
    J Y Ko
    Department of Otolaryngology, National Taiwan University Hospital, Taipei
    Arch Otolaryngol Head Neck Surg 124:578-81. 1998
    ..Head and neck cancers, however, represent a heterogeneous group of neoplasm. The biological behavior of nasopharyngeal carcinoma (NPC) and other head and neck cancers differs...
  9. ncbi request reprint Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men
    Y C Chien
    Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    N Engl J Med 345:1877-82. 2001
    ..CONCLUSIONS: IgA antibodies against EBV capsid antigen and neutralizing antibodies against EBV DNase are predictive of nasopharyngeal carcinoma...
  10. ncbi request reprint Intracranial relapse of nasopharyngeal carcinoma manifested as sudden deafness
    Y H Young
    Department of Otolaryngology, College of Medicine, National Taiwan University, Taipei
    Otol Neurotol 22:392-6. 2001
    ..CONCLUSION: Magnetic resonance imaging should be performed to exclude intracranial relapse if sudden deafness develops in a patient with NPC within 5 years after irradiation...
  11. ncbi request reprint Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
    A L Cheng
    Department of Internal Medicine, National Taiwan University College of Medicine, Taipei
    Anticancer Res 21:2895-900. 2001
    ..In conclusion, this study demonstrated that curcumin is not toxic to humans up to 8,000 mg/day when taken by mouth for 3 months. Our results also suggest a biologic effect of curcumin in the chemoprevention of cancer...
  12. ncbi request reprint Stretch-activated nonselective cation, Cl- and K+ channels in apical membrane of epithelial cells of Reissner's membrane
    T H Yeh
    Department of Otolaryngology, National Taiwan University Hospital, Taipei
    Hear Res 109:1-10. 1997
    ..These channels might play roles in the regulation of cell volume, in balancing the hydrostatic pressure across Reissner's membrane and in maintaining the electrochemical composition of endolymph...
  13. ncbi request reprint Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA
    Ruey Long Hong
    Department of Oncology, National Taiwan University Hospital, College of Medicine, Taipei, Taiwan
    Cancer 100:1429-37. 2004
    ..The objective of the current study was to assess the effectiveness of plasma EBV DNA monitoring in the early detection of NPC recurrence compared with conventional methods...
  14. ncbi request reprint Herpes zoster oticus treated with acyclovir and prednisolone: clinical manifestations and analysis of prognostic factors
    J Y Ko
    Department of Otolaryngology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan
    Clin Otolaryngol Allied Sci 25:139-42. 2000
    ..Multiple nerve palsies and age had negative effects on the improvement...
  15. ncbi request reprint Quality of life in patients of nasopharyngeal carcinoma: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
    W C Chie
    School of Public Health and Graduate Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    Qual Life Res 12:93-8. 2003
    ....
  16. ncbi request reprint Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma
    Jenq Yuh Ko
    Department of Otolaryngology, College of Medicine, National Taiwan University, Taipei, Taiwan
    Cancer 94:1987-96. 2002
    ....
  17. ncbi request reprint Failure of grommet insertion in post-irradiation otitis media with effusion
    C Y Chen
    Department of Otolaryngology, National Taiwan University Hospital, Taipei
    Ann Otol Rhinol Laryngol 110:746-8. 2001
    ..In conclusion, post-irradiation OME should be treated in a different way from conventional OME. Restated, grommet insertion is contraindicated in post-irradiation OME...
  18. ncbi request reprint Potassium-titanyl-phosphate laser nasopharyngectomy with nasopharyngoscopic guidance for recurrent nasopharyngeal carcinoma
    Ching Ting Tan
    Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
    J Formos Med Assoc 104:960-3. 2005
    ..Our results suggest that this technique is useful for excising locally recurring nasopharyngeal carcinomas. Prospective trial of this technique with long-term follow-up is necessary to determine its effectiveness and safety...
  19. ncbi request reprint Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan
    Allan Hildesheim
    Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Rm 7062, Rockville, MD 20852, USA
    J Natl Cancer Inst 94:1780-9. 2002
    ..We used high-resolution HLA genotyping in a case-control study in Taiwan to systematically evaluate the association between various HLA alleles and NPC...
  20. ncbi request reprint No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan
    Yu Juen Cheng
    Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, 100 Taiwan
    Cancer Epidemiol Biomarkers Prev 12:179-80. 2003
  21. ncbi request reprint Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1
    En Yu Cho
    Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei 10018, Taiwan
    Cancer Epidemiol Biomarkers Prev 12:1100-4. 2003
    ..5-177). Polymorphisms of the DNA repair genes hOGG1 (codon 326) and XRCC1 (codon 280) are associated with an altered risk of NPC. Carriers of multiple putative high-risk genotypes have the highest risk of developing NPC...
  22. ncbi request reprint Epstein-Barr virus seroreactivity among unaffected individuals within high-risk nasopharyngeal carcinoma families in Taiwan
    Amy Pickard
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Int J Cancer 111:117-23. 2004
    ..Unaffected individuals from high-risk NPC families have elevated anti-EBV IgA antibody titers. The etiologic and clinical implications of this finding remain to be established...
  23. ncbi request reprint Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
    Anthony T C Chan
    Cancer Therapeutics Reserach Group, Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, HKSAR, China
    J Clin Oncol 23:3568-76. 2005
    ..To evaluate efficacy and toxicity of cetuximab plus carboplatin in recurrent or metastatic nasopharyngeal carcinoma (NPC) resistant to platinum treatment...